EMEA-000408-PIP02-12

Key facts

Invented name
Firazyr
Active substance
icatibant
Therapeutic area
Other
Decision number
P/0282/2012
PIP number
EMEA-000408-PIP02-12
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of ACE inhibitor-induced angioedema
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Shire Orphan Therapies GmbH
United States
E-mail: medinfoeu-ceemea@shire.com
Tel. +44 (0)2196 65520
Fax +1 7814822954
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating